GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inner Mongolia Furui Medical Science Co Ltd (SZSE:300049) » Definitions » Beneish M-Score

Inner Mongolia Furui Medical Science Co (SZSE:300049) Beneish M-Score : -2.60 (As of Apr. 24, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Inner Mongolia Furui Medical Science Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.6 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Inner Mongolia Furui Medical Science Co's Beneish M-Score or its related term are showing as below:

SZSE:300049' s Beneish M-Score Range Over the Past 10 Years
Min: -30.02   Med: -2.52   Max: 1.52
Current: -2.6

During the past 13 years, the highest Beneish M-Score of Inner Mongolia Furui Medical Science Co was 1.52. The lowest was -30.02. And the median was -2.52.


Inner Mongolia Furui Medical Science Co Beneish M-Score Historical Data

The historical data trend for Inner Mongolia Furui Medical Science Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inner Mongolia Furui Medical Science Co Beneish M-Score Chart

Inner Mongolia Furui Medical Science Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.73 -4.84 -2.42 -2.84 -2.50

Inner Mongolia Furui Medical Science Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 -2.57 -2.45 -2.50 -2.60

Competitive Comparison of Inner Mongolia Furui Medical Science Co's Beneish M-Score

For the Biotechnology subindustry, Inner Mongolia Furui Medical Science Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inner Mongolia Furui Medical Science Co's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inner Mongolia Furui Medical Science Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Inner Mongolia Furui Medical Science Co's Beneish M-Score falls into.


;
;

Inner Mongolia Furui Medical Science Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Inner Mongolia Furui Medical Science Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0205+0.528 * 1.0011+0.404 * 0.991+0.892 * 1.0989+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9944+4.679 * -0.051662-0.327 * 0.9493
=-2.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Total Receivables was ¥558 Mil.
Revenue was 330.402 + 369.154 + 337.234 + 319.824 = ¥1,357 Mil.
Gross Profit was 253.63 + 250.354 + 259.322 + 243.023 = ¥1,006 Mil.
Total Current Assets was ¥1,521 Mil.
Total Assets was ¥3,079 Mil.
Property, Plant and Equipment(Net PPE) was ¥498 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥199 Mil.
Total Current Liabilities was ¥333 Mil.
Long-Term Debt & Capital Lease Obligation was ¥50 Mil.
Net Income was 28.637 + 11.283 + 26.638 + 32.645 = ¥99 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 75.324 + 99.999 + 16.775 + 66.153 = ¥258 Mil.
Total Receivables was ¥498 Mil.
Revenue was 322.804 + 346.732 + 282.517 + 282.42 = ¥1,234 Mil.
Gross Profit was 247.277 + 241.941 + 210.287 + 217.265 = ¥917 Mil.
Total Current Assets was ¥1,335 Mil.
Total Assets was ¥2,684 Mil.
Property, Plant and Equipment(Net PPE) was ¥416 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥182 Mil.
Total Current Liabilities was ¥301 Mil.
Long-Term Debt & Capital Lease Obligation was ¥51 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(558.16 / 1356.614) / (497.691 / 1234.473)
=0.411436 / 0.403161
=1.0205

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(916.77 / 1234.473) / (1006.329 / 1356.614)
=0.742641 / 0.741795
=1.0011

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1520.573 + 498.233) / 3078.65) / (1 - (1335.256 + 416.317) / 2683.857)
=0.344256 / 0.347367
=0.991

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1356.614 / 1234.473
=1.0989

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 416.317)) / (0 / (0 + 498.233))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(199.096 / 1356.614) / (182.2 / 1234.473)
=0.14676 / 0.147593
=0.9944

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((50.436 + 333.192) / 3078.65) / ((51.035 + 301.255) / 2683.857)
=0.124609 / 0.131263
=0.9493

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(99.203 - 0 - 258.251) / 3078.65
=-0.051662

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Inner Mongolia Furui Medical Science Co has a M-score of -2.60 suggests that the company is unlikely to be a manipulator.


Inner Mongolia Furui Medical Science Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Inner Mongolia Furui Medical Science Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Inner Mongolia Furui Medical Science Co Business Description

Traded in Other Exchanges
N/A
Address
No. 103 Jiefang Road, Wulanchabu League, Inner Mongolia Autonomous Region, Jining, CHN, 012000
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
Executives
Di Xiu Juan Executives
Lin Xin Directors, Directors, and Executives
Wang Guan Yi Director
Wang Li Qun Supervisors
Wang Xin Hong Executives
Shuo Fei Directors, executives
Zhang Sui Yong Director
Zhao Xiao Dong Independent director
Yang Jin Bin Supervisors

Inner Mongolia Furui Medical Science Co Headlines

No Headlines